ResMed | RMD - Current Liabilities



ResMed reported $1.02B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Ansell USD 423.4M 200K Jun/2024
AtriCure USD 68.84M 7.62M Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Cochlear AUD 626.1M 5.4M Dec/2024
Cooper Companies USD 1.01B 2.4M Jul/2025
CSL USD 6.07B 1.12B Dec/2024
Dexcom USD 3.31B 271.6M Jun/2025
Edwards Lifesciences USD 1.39B 110.4M Mar/2025
Fisher Paykel Healthcare NZD 500.4M 127.5M Mar/2025
Globus Medical USD 424.66M 39.96M Jun/2025
Haemonetics USD 531.41M 46.71M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Idexx Laboratories USD 1.22B 87.67M Jun/2025
Insulet USD 1.01B 489.7M Jun/2025
Integra LifeSciences USD 929.81M 11.35M Jun/2025
Intuitive Surgical USD 2.21B 197.4M Jun/2025
Masimo USD 592.1M 45.6M Jun/2025
Medtronic USD 12.88B 1.04B Apr/2025
Philips EUR 7.2B 445M Jun/2025
Ramsay Health Care AUD 3.72B 465.1M Dec/2024
ResMed USD 1.02B 78.6M Jun/2025
Sigma Healthcare AUD 701.53M 330.25M Jul/2024
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Steris USD 926.6M 95.57M Jun/2025
Teleflex USD 716.15M 40.24M Jun/2025
Thermo Fisher Scientific USD 12.72B 456M Jun/2025